Phase I, open-label, dose-escalation trial investigating the safety and efficacy of oncolytic virus BI 1821736 in patients with advanced solid tumors.

被引：0

作者：

Tolcher, Anthony W.

Victoria, Ivan

Germann, Nathalie

Luecke, Stephan

Bailey, Mark

Kordes, Maximilian

机构：

[1] NEXT Oncol, San Antonio, TX USA

[2] Hosp Clin Barcelona, Barcelona, Spain

[3] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[4] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany

[5] Boehringer Ingelheim Ltd, Bracknell, Berks, England

[6] Karolinska Univ Hosp, Solna, Sweden

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS2688

引用

页数：1